CYP26A1 Is a Novel Cancer Biomarker of Pancreatic Carcinoma: Evidence from Integration Analysis and In Vitro Experiments

Figure 2

CYP26A1 was a prognosis biomarker of PC. Notes: (a)–(c) Kaplan-Meier survival curves of OS, DSS, and PFI indicated the prognosis value of CYP26A1, respectively. (d)–(f) ROC curves of OS, DSS, and PFI indicated the prognosis value of CYP26A1, respectively. (g)–(i) Multivariate Cox analysis showed that CYP26A1 was an independent prognosis factor of OS, DSS, and PFI.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)